ʻeho peni mäka CA 19-9. Ka Ikepili o CA 19-9: kūmau, a ia ia i hoaka ai

ʻeho peni mäka CA 19-9 mea he kiʻekiʻe hakakino kaumaha glycoprotein. Ua ua hua mai ma keena ma ka epithelium o ka digestive nenoaiu. E like me ka noiʻi hana hoʻohana immunohemilyuminestsentny Ka Ikepili. CA 19-9 Ua pili me ka cancerous pathologies.

kekahi mau 'ike

E hoʻopaʻa haʻawina i ka liluwelo nā like ua hoʻohana 'venous koko. CA 19-9 - he pono kaʻeho peni mäka. Kona wehewehena ua hoʻohana 'ia i loko o kaʻike,, ka mālamaʻana a me ka i kakahiaka nui ka loaʻaʻana o ka metastasis i loko o ka'ōpū, pancreas, akepaa, liʻiliʻi (AeXIeAaOIePEAaI a me ka rectum). CA 19-9 pae nui ae la ka aneane e pau loa nā mea maʻi me ka gastrointestinal hikoko, oi loa o ka pancreas. Ka hana keena ma ka hikoko, glycoprotein komo i loko o ka systemic holo. Malama a me ka loiloi 'i ka maʻiʻo, i ka poe akamai i ka manawa maopopo, e hahai aku i ka papa o ka maʻi. Ka Ikepili o CA19-9, ka uku o ka i loko o ke ola i ke kanaka, 'aʻole hoʻohana' ia i oi aku mamua o 10 U / ml i loko o ka puke Paipala iʻike.

He aha ka pancreatic Ka maʻi 'aʻai? hōʻuluʻulu manaʻo

Kēia oncological maʻi i ka lā ua komo i loko o ka papa inoa o ka noho pilikia loa pathologies. 90% o nā mea maʻi e make i loko o ka makahiki mua o ka maʻi. I ka manawa o kaʻike, i loko o 80% o nā mea maʻi i ke keʻena a me nā 'āina' metastases. Poe akamai i ke kaila kēiaʻano nui i hūnāʻia ma luna o ka pathology. Ka maʻi pinepine hūnā like maʻi hoʻoʻino keʻano o ka hanaʻana i loko o ka pele ciia hepatopancreatoduodenal nā loko (cholelithiasis, cholecystitis, maʻi pancreatitis). Ma pili ana i keia e pono e like me ka hikiwawe e loaa, e lawe mai i ka palena pauʻike,, Ma waho aʻeo ka i ke alo o ke malignancy. Kēia, ma ka huli, e koho i ka loa ka hoʻokō pākōlea kou akamai o kēia mau maʻi ana.

Antigen CA 19-9. lehulehu

I Ka maʻi 'aʻai o ka pancreas he mea he nui kiʻekiʻe o ka glycoprotein. Ka Ikepili o CA19-9, a iloko ona i kakauia na luna rula, pono i ka ka loaʻaʻana o ka carcinoma, ka loiloi 'manawa kūpono o ka resection. Ma ka lehulehu o ka oi ma mua o 1000 U / ml neoplasm manaoia operable wale 5% o nā mea maʻi. Inā ka maʻiʻo o lalo o ka hōʻike huahelu, kaʻeho ana hiki ke wehe. Eia naʻe, ma hope o ka piʻiʻana o ka wā o kekahi i ehiku mahina, aia no he pilikia o ka recurrence. ʻeho peni mäka CA 19-9 o ka lua ma ka nui ma hope o ka peni mäka CEA no kaʻimiʻana malignancy i loko o ka'ōpū. Eia hou, i ke ao hou kiʻekiʻe hakakino kaumaha glycoprotein häʻawi mai ai iä Alpha-fetoprotein i loko o kaʻike, a me ka mālamaʻana o ka hana o ke akepaa Ka maʻi 'aʻai, biliary'āpana a me ka bladder.

mea ulu o

Ke kiekie pae o ka glycoprotein hiki e malama ma ke kāʻei kua o kela hoʻoʻino a me ka benign pathologies i loko o ke ake, a me ka digestive nenoaia (i ka 500, akā, IeAUPIIe, IAa IO i 100 U / ml), a me ka cystic fibrosis. Ma ka hihia mua o ka lehulehu ua mahuahua ma ka 12% o nā mea maʻi. ʻO kā mākou 'ilikai i keia - i hou aku 45 U / ml. Glycoprotein excreted i loko o ka bile. Ma keia pili ana, i kekahi cholestasis i ke ukali ma ka hoomahuahua i loko o kona maʻiʻo. Ma na hihia ia mea pono e hoʻomaka noiʻi ka poʻe GGT (gamma-glutamattransferazy) a me kona'ākilikai phosphatase. Mahuahua lehulehu Hiki ke malama no hoi ma ke kāʻei kua o nā localizing hikoko (i loko o colorectal Ka maʻi 'aʻai, ovarian Ka maʻi' aʻai), ake maʻi (cirrhosis, hepatitis).

Wa e kaawale aku ai hoemiia kaʻilikai

Mau loea, ua kaulana ia maʻamau lehulehu 'aʻole e hookaawale ia i ke alo o ka maʻi' aʻai i loko o ka pancreas. Ma keia hihia, ka mea hiki ke diagnosed kakahiaka nui ke kahua maʻi i ka wa a ke piʻi nei ke ole nae he manawa e ala. Ke like i loko o nā mea maʻi loaa lapaau, ua hakumakuma i ka maʻiʻo o ka glycoprotein ke hōʻike i ka hopenaʻoi loa o pākōlea uao ai '.

I pono noiʻi

Ka hoao ana no kaʻeho peni mäka CA 19-9 ua pono e kanaka hoʻoponopono i ka laulā o ka pākōlea uao ai 'no pancreatic Ka maʻi' aʻai, e like me ka wanaʻao ka loaʻaʻana o ka maʻi recurrence. Ke kuka nei lakou e leie aku i ka palena pauʻike, o ka malignancy a me nā maʻi (e laʻa me, pancreatitis). Anakahi CA 19-9 hōʻike i ka prevalence o malignant kaʻina, ke alo o ka maʻi 'aʻai i loko o ke kāʻei kua o ka loihi mai metastases o ka maʻi.

Ma kekahi mau hihia, o ka ia study

Ka hoao ana no kaʻeho peni mäka CA 19-9 ua pono no ka hoike ana o na symptoms o Ka maʻi 'aʻai o na pancreas: nausea,ʻeha i loko o ka abdomen, jaundice, ke kaupaonaʻana me keia poho. Kekahi manawa hāʻawi like nā mea maʻi me ka lehulehu initially kiʻekiʻe o glycoprotein a loaa lapaau. Ka Ikepili paipai no kēia maʻi 'aʻai i loko o ke au bladder a biliary'āpana, akepaa,'ōpū a me AeXIeAaOIePEAaI. Research pela lawelawe ma ka hoʻohui pū 'ia me nā ho'āʻo ma.

transcript

Ka pili waiwai huahelu a pono e kiʻekiʻe o ka antigen - 0-35 U / ml. Me ua i haiia ae maluna, o ka lehulehu kiʻekiʻe o glycoprotein Hōʻike ke alo o ka malignancy i loko o ka pancreas. Ke kiekie o ka maʻiʻo, i ka nui holomua ke kahua maʻi. Excessive pae hoikeʻeho metastasis.

nui 'ike

Hōʻike maʻiʻo noonoo glycoprotein mea pakahi aku la ia nui i loko o ke kakahiaka ka loaʻaʻana o metastatic laha o ka maʻi 'aʻai i loko o ka pancreas. About 7-10% o kanaka e, aole i ka'ōewe e encodes ke kiʻekiʻe hakakino kaumaha glycoprotein. Alaila, ma ke kino, he mea he aaiaoe uea e synthesize i ka antigen CA 19-9. Penei, a hiki i kaʻike, o ka malignancy pae o ka glycoprotein ua ole 'akomi i loko o ka lāʻau lapaʻau.

No ka 'ike hou aku,

Mua oe E lūlū mai ke koko, poe akamai i waiho mai i ka uahi no ka hapalua o ka hora. Ka lapaʻau 'ana waiwai o ka hoao ana, piʻi pū, oiai ka study ma CEA. Ma waho aʻeo ia ana i ka loa pololeiʻike, a me ke kūpono koho pono lapaʻau paipaiʻia e ho'āʻo ai no CA 72-4, huina bilirubin, CA 242. keʻena hoʻokolohua haʻawina hoonoho i iaʻano poʻe i hepatologist, internist, surgeon paha oncologist.

ka hopena

Mau loea, e hoailona oukou i keia la Ka maʻi 'aʻai ana ma na pancreas i increasingly, he pono ole i ka hoʻomanawanuiʻana ma hope o 30 makahiki. Kēia pathology He hoʻokahi loa poorly akomi a poorly amenable i ka Inc. Ma keia manao, ua pono ka loa ikepili koʻikoʻi e ho'āʻo ai, e hōʻike iā ia. Eia naʻe, i ka study o antigen lehulehu hiki ole ke hoʻohana 'ia no ka loiloi muaʻike, o ka maʻi ke kahua. Aka hoi, ua ho'āʻo o ka loa a me ka 'ikepili koʻikoʻi informative no ka loiloi' ana i ka laulā o ka lapaʻau, ka loaʻaʻana o nā kahua o ka hoʻonaʻauao i kakahiaka nui o ka metastasis o ka maʻi 'aʻai. Oiaio no, he hoʻomalu i loko o ka anamanaʻo hoʻohana i ka hopena o nā PalekanaEND_LINK kaʻina hana. Ma waho aʻeo ia i ke keʻena hoʻokolohua, ke hoʻomanawanui ua kohoia a vocal noiʻiʻana. Ka loa ole o kēia mau mea e ka 'Amelika. Ma ka hoʻokō 'ia' o kona 'oihana e kuhikuhi i kaʻeho nui mai mau kenimika. E möakäka hou i ka nui, kulana, a me ka laha ana o malignancy i koi 'ia ke HI scan NineManga.com. E ho ohana i keia hana, ka mea hiki ke 'akomi i maiʻeho nui ekolu mau kenimika. Ua pono e mai la oia i ka hana o ke HI ua pili i ka paka i kekahi mahele lāʻau o ka X-kukuna. Nolaila, ua ao ia i hana pinepine ai me prophylaxis. Emi stress ma ka hoʻomanawanui ka kino hoʻolako ka MRI. Akā, ua i lawe mai i ka mea i kekahi mea hiki ke hooheheeia implants keia ano keia ano o ka noiʻi. A pau o kēia mau PalekanaEND_LINK ana, a me ke koko e ho'āʻo ai e huai ae i kakahiaka nui kahua o ka hoʻonaʻauao o ka maʻi 'aʻai? Acaeoey a metastasis i loko o ka pancreas.